NNXXY yields 102.56% · JNJ yields 2.13%● Live data
📍 NNXXY pulled ahead of the other in Year 1
Combined, NNXXY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NNXXY + JNJ for your $10,000?
Nexity SA operates as a real estate company in Europe and internationally. The company operates through Development, Services, and Other Activities divisions. It develops new homes and subdivisions; and new or refurbished office buildings, high-rises, business parks, logistics facilities, retail property, hotels, and other industrial spaces. The company also provides property management services comprising rental management, sales and lettings, and condominium managing agent services, as well as manages serviced residences for students and for seniors; distributes real estate products under the iSelection and PERL brands; offers real estate brokerage, and space planning services; and real estate services, including rental management and property management services. In addition, it engages in the villes and projets, and pre-development urban regeneration project activities; and investment activities, as well as startup in the incubation phase. The company serves individual, commercial, institutional, and local authority clients. Nexity SA was founded in 1995 and is headquartered in Paris, France.
Full NNXXY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.